Correlation Analysis
Eli Lilly & Co. vs Thermo Fisher Scientific, Inc.
LLY vs TMO
-0.073
Weak inverse
When one moves up, the other tends to move down.
Eli Lilly & Co.
↗LLY
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Market cap 828.2B · 50,000 employees
Thermo Fisher Scientific, Inc.
↗TMO
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Market cap 181.4B
Time Series
Relative Performance
Who Moves First
LLY leads TMO by 6 days
LLY tends to move before TMO.
After testing 13 timing shifts, the strongest relationship was -0.093 (they moved in opposite directions).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
-0.269
16 periods · Return correlation when both series rose
Both Falling
-0.262
8 periods · Return correlation when both series fell
Diverging
-0.541
11 periods · Return correlation when series moved apart
R-Squared
0.5%
Share of variance in one series explained by the other.
Trend Agreement
59.7%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,254
Deep shared window — 1,254 usable pairs.
Significance
p < 0.05
95% CI: [-0.128, -0.017]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,254 paired data points survived the daily window.
Raw input
1,254
1,254
Normalized
1,254
1,254
Prepared
1,254
1,254
Aligned
1,254
1,254
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
0
A: 0 / B: 0
Series A
Eli Lilly & Co.
LLY
Market cap 828.2B · 50,000 employees
Stock · 1,254 raw → 1,254 prepared
Series B
Thermo Fisher Scientific, Inc.
TMO
Market cap 181.4B
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
3
Estimated crossover points between normalized spreads.
Slope
-0.0143
Linear regression slope.
Intercept
547.7917
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
Saved 6 hours ago · ID: stock-lly-vs-stock-tmo-daily